$57.11
0.32 (+0.56%)
United Therapeutics Corp (NASDAQ:UTHR)
CAPS Rating:
A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.
RSS Headlines
Fool UK